乳腺癌综合治疗565例分析  

A Clinical Analysis on Breast Carcinoma with Combination Therapy in 565 Cases

作　　者：郭友全[1] 李长青[1] 顾兴华[1] 藏爱华[1] 柯玉华[1] 张明和[1] 

机构地区：[1]湖北省肿瘤医院,武昌430070

出　　处：《肿瘤学杂志》1995年第4期233-235,共3页Journal of Chinese Oncology

摘　　要：1976年～1984年共收治565例乳腺癌。3、5年生存率分别为68．5％；58．98％。分为四组治疗．5年生存率Ⅰ期～Ⅳ期：单纯手术组为90％（9／10）；69％（29／42）；35％（7／20）；0％（0／13）。手术加放疗组分别96％（22／23）；74％（66／89）；51％（25／49）；15％（4／26）．手术加放化疗组分别为75％（18／24）；73％（46／63）；61％（41／67）；22％（8／36）。手术加化疗组为83％（5／6）；61％（14／23）；53％（9／17）；0（0／8）。病理类型与预后有关。作者认为Ⅰ期乳癌行根治术或小手术加放疗，ⅢⅣ期行手术加放化疗的综合治疗能提高疗效。From 1976 to 1984. 565 patients with breast carcinoma were treated in this hospital. the 3- and 5-years survival rates were 68. 5 % and 59. 3 % respectively. The patients were divided into 4 group. and the 5-years survival rate of stage Ⅰto Ⅳ in each group respectively was as follows. Surgery alone 90%(9 /10). 69 % (29 /42 ), 35%(7/20). 0(0 /13); Surgery plus radiotherapy 96%(22/23), 74 % (66 /89 ), 51 % (25 /49 ), 15 % (4/26 ): Surgery plus radiotherapy and chemotherapy 75% (18 /24 ), 73% (46 /63 ),61 % (41 /67), 22 % (8/36 ); Surgery plus chemotherapy 83% (5/6). 61% (14/23). 53%(9 /17 ), 0(0/8 ).This study suggests that the classification of pathology is related to the prognoris of breast carcinoma. both the radical operation or operation plus radiotherapy are the choice for stage Ⅰpatients, combining the surgery with radiotherapy and chemotherapy can improve the treating effect for stageⅢ and Ⅳ patients.

关 键 词：乳腺癌 手术 放射治疗 化疗 

分 类 号：R737.9[医药卫生—肿瘤]